Drugs Made In America Acquisition Corp. (DMAAR) Other Non-Current Assets (2024)

Drugs Made In America Acquisition (DMAAR) has reported Other Non-Current Assets for 1 consecutive years, with $545833.0 the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Other Non-Current Assets changed N/A year-over-year to $545833.0; the trailing twelve-month figure through Dec 2024 stood at $545833.0 (changed N/A YoY), and the FY2024 full-year result was $545833.0, changed N/A from the prior year.
• Other Non-Current Assets was little changed at $545833.0 in Q4 2024 per DMAAR's latest filing.
• Across five years, Other Non-Current Assets topped out at $545833.0 in Q4 2024 and bottomed at $545833.0 in Q4 2024.